Multivoxel magnetic resonance spectroscopy identifies enriched foci of cancer stem-like cells in high-grade gliomas

References

• LouisDNOhgakiHWiestlerODThe 2007 WHO classification of tumours of the central nervous systemActa Neuropathol200711429710917618441
   PubMed Web of Science ®Google Scholar
• OstromQTGittlemanHLiaoPCBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011Neuro Oncol201416suppl 4iv1iv6325304271
   PubMed Web of Science ®Google Scholar
• BaoSWuQMcLendonREGlioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature2006444712075676017051156
   PubMed Web of Science ®Google Scholar
• ChenJLiYYuTSA restricted cell population propagates glioblastoma growth after chemotherapyNature2012488741252252622854781
   PubMed Web of Science ®Google Scholar
• IgnatovaTNKukekovVGLaywellEDSuslovONVrionisFDSteindlerDAHuman cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitroGlia200239319320612203386
   PubMed Web of Science ®Google Scholar
• LathiaJDMackSCMulkearns-HubertEEValentimCLRichJNCancer stem cells in glioblastomaGenes Dev201529121203121726109046
   PubMed Web of Science ®Google Scholar
• ClarkPMMaiWXCloughesyTFNathansonDAEmerging approaches for targeting metabolic vulnerabilities in malignant gliomaCurr Neurol Neurosci Rep20161621726759318
   PubMedGoogle Scholar
• GlundeKBhujwallaZMRonenSMCholine metabolism in malignant transformationNat Rev Cancer2011111283584822089420
   PubMed Web of Science ®Google Scholar
• CaroPKishanAUNorbergEMetabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphomaCancer Cell201222454756023079663
   PubMed Web of Science ®Google Scholar
• HensleyCTFaubertBYuanQMetabolic heterogeneity in human lung tumorsCell2016164468169426853473
   PubMed Web of Science ®Google Scholar
• TerunumaAPutluriNMishraPMYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosisJ Clin Invest2014124139841224316975
   PubMed Web of Science ®Google Scholar
• Martinez-BisbalMCCeldaBProton magnetic resonance spectroscopy imaging in the study of human brain cancerQ J Nucl Med Mol Imaging200953661863020016453
   PubMed Web of Science ®Google Scholar
• HouraniRBrantLJRizkTWeingartJDBarkerPBHorskaACan proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults?AJNR Am J Neuroradiol200829236637218055564
   PubMedGoogle Scholar
• UseniusJPVainioPHernesniemiJKauppinenRACholine-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitroJ Neurochem1994634153815437931308
   PubMedGoogle Scholar
• BruhnHFrahmJGyngellMLNoninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumorsRadiology198917225415482748837
   PubMedGoogle Scholar
• ZengQLiuHZhangKLiCZhouGNoninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopyMagn Reson Imaging2011291253120832225
   PubMedGoogle Scholar
• WangQZhangHZhangJThe diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: a systematic review and meta-analysisEur Radiol20162682670268426471274
   PubMedGoogle Scholar
• FinkJRCarrRBMatsusueEComparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effectsJ Magn Reson Imaging2012351566322002882
   PubMed Web of Science ®Google Scholar
• ZhangZZengQLiuYLiCFengDWangJAssessment of the intrinsic radiosensitivity of glioma cells and monitoring of metabolite ratio changes after irradiation by 14.7-T high-resolution (1)H MRSNMR Biomed201427554755224677622
   PubMedGoogle Scholar
• ZhangJZhuangDXYaoCJMetabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resectionJ Neurosurg201612461585159326636387
   PubMedGoogle Scholar
• NajbauerJZhaoJHeHNeuronal transcription factors induce conversion of human glioma cells to neurons and inhibit tumorigenesisPLoS One201277e4150622859994
   PubMedGoogle Scholar
• BresciaPRichichiCPelicciGCurrent strategies for identification of glioma stem cells: adequate or unsatisfactory?J Oncol2012201237689422685459
   PubMedGoogle Scholar
• EllisHPGreensladeMPowellBSpiteriISottorivaAKurianKMCurrent challenges in glioblastoma: intratumour heterogeneity, residual disease, and models to predict disease recurrenceFront Oncol2015525126636033
   PubMed Web of Science ®Google Scholar
• BlochOHanSJChaSImpact of extent of resection for recurrent glioblastoma on overall survival: clinical articleJ Neurosurg201211761032103823039151
   PubMed Web of Science ®Google Scholar
• JohnsonBEMazorTHongCMutational analysis reveals the origin and therapy-driven evolution of recurrent gliomaScience2014343616718919324336570
   PubMed Web of Science ®Google Scholar
• OhkaFNatsumeAWakabayashiTCurrent trends in targeted therapies for glioblastoma multiformeNeurol Res Int2012201287842522530127
   PubMedGoogle Scholar
• LinARossBDHarrisKWongWEfficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision makingNeuroRx20052219721415897945
   PubMedGoogle Scholar
• NelsonSJMultivoxel magnetic resonance spectroscopy of brain tumorsMol Cancer Ther20032549750712748312
   PubMedGoogle Scholar
• VermaAKumarIVermaNAggarwalPOjhaRMagnetic resonance spectroscopy – revisiting the biochemical and molecular milieu of brain tumorsBBA Clin2016517017827158592
   PubMed Web of Science ®Google Scholar
• NiculescuMDZeiselSHDiet, methyl donors and DNA methylation: interactions between dietary folate, methionine and cholineJ Nutr20021328 suppl2333S2335S12163687
   PubMed Web of Science ®Google Scholar
• WickWWellerMvan den BentMMGMT testing – the challenges for biomarker-based glioma treatmentNat Rev Neurol201410737238524912512
   PubMed Web of Science ®Google Scholar
• LeeJSonMJWoolardKEpigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cellsCancer Cell2008131698018167341
   PubMedGoogle Scholar
• McKnightTRLambornKRLoveTDCorrelation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomasJ Neurosurg2007106466066617432719
   PubMedGoogle Scholar
• ShimizuHKumabeTShiraneRYoshimotoTCorrelation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomasAJNR Am J Neuroradiol200021465966510782774
   PubMedGoogle Scholar
• CaivanoRLotumoloARabascoP3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literatureInt J Neurosci2013123853754323390934
   PubMed Web of Science ®Google Scholar
• HermansenSKChristensenKGJensenSSKristensenBWInconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastomaJ Histochem Cytochem201159439140721411810
   PubMedGoogle Scholar
• ZhangMSongTYangLNestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patientsJ Exp Clin Cancer Res2008278519108713
   PubMed Web of Science ®Google Scholar
• SonMJWoolardKNamDHLeeJFineHASSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastomaCell Stem Cell20094544045219427293
   PubMed Web of Science ®Google Scholar
• YamamuroSOkamotoYSanoECharacterization of glioma stem-like cells from human glioblastomasInt J Oncol2015471919625955568
   PubMedGoogle Scholar